MAR vs UNH: Which Is the Better Buy?
Side-by-side comparison of Marriott International, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
Marriott International, Inc. · Consumer Cyclical
$366.24
-3.4% upside to fair value
Med Conviction
Grade C
VS
UnitedHealth Group Incorporated · Healthcare
$423.38
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MAR |
UNH |
| Current Price |
$366.24 |
$423.38 |
| Fair Value Estimate |
$353.64 |
$613.90 |
| Upside to Fair Value |
-3.4%
|
+45.0%
|
| Market Cap |
$96.6B |
$384.5B |
| Forward P/E |
—
|
27.2x
|
| EV / EBITDA |
23.8x
|
13.8x
|
| Price / Sales |
3.7x
|
0.8x
|
| Price / FCF |
31.6x
|
19.6x
|
| Revenue Growth YoY |
+6.2%
|
+0.4%
|
| Gross Margin |
21.4%
|
18.8%
|
| Operating Margin |
16.0%
|
4.2%
|
| Return on Equity |
-74.1%
|
12.4%
|
| Dividend Yield |
0.75% |
0% |
| FCF Yield |
3.17%
|
5.12%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Marriott International is a global asset-light hotel franchisor, manager and licensor whose high-quality brands, nearly 283 million Bonvoy members, more than 9,900 properties across 146 countries and record 4,107-property development pipeline create meaningful network, distribution and brand advantages. Q1 2026 demonstrated resilient underlying fee economics: adjusted revenue excluding cost-reimb…
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by a…
Accumulation Zones
| Metric |
MAR |
UNH |
| Zone Low |
$265.23 |
$460.42 |
| Zone High |
$300.59 |
$521.81 |
| In Buy Zone? |
No
|
Yes
|